mild® removes a major root cause of lumbar spinal stenosis (LSS) to improve back and leg pain.
mild® for Patients
An hour may change everything for patients with lumbar spinal stenosis (LSS). Find out how this minimally invasive, outpatient procedure, which has a safety profile similar to an epidural steroid injection (ESI), may help you stand longer and walk farther with less pain.
Pain, numbness or tingling in legs or buttocks when walking
Relief when sitting or leaning forward
mild® for Healthcare Professionals
Help your LSS patients, even those with comorbidities, by removing a major root cause of their neurogenic claudication. Move to mild® to provide patients with long-term relief using a therapy that has a safety profile equivalent to an ESI, but with lasting results. Learn more about the minimally invasive mild® Procedure’s key benefits, clinical outcomes and how it can be incorporated into your treatment algorithm.
Case History: 75 year-old male with a history of 3 prior spine surgeries, which included laminectomies at L4-5 and L5-S1. Noticing his lower back pain worsening and requiring more assistance with ambulation, he completed a full course of physical therapy with little improvement. He was later treated with 2 bilateral epidural steroid injections (ESIs), which offered temporary pain relief, but no functional improvement. The patient could only stand/walk for less than 10 minutes, progressed from a cane to a walker, and moved to a recliner to sleep.
Answer: Yes! The featured patient was an excellent Mild candidate who achieved significant improvement in quality of life and mobility. By his two week follow-up, the patient could stand for more than 30 minutes, resumed walking up to two miles, and threw out his cane and walker.
If you think your patient may have lumbar spinal stenosis (#LSS), look for signs of the "shopping cart syndrome" to evaluate symptoms, which may include pain in the lower back, lower extremities, or buttocks that is relieved with forward flexion (like leaning on a shopping cart). These symptoms indicate your patient may be a candidate for the Mild Procedure.
Mild is a minimally invasive lumbar decompression with a safety profile equivalent to an epidural steroid injection (ESI).* Get your patients on the path to relief by making the #MOVE2mild early in your treatment algorithm.
New #MildProcedure data was revealed at the @pacificspineandpainsociety (PSPS) 2021 Annual Conference! This real-world retrospective data confirms that lumbar spinal stenosis (#LSS) patients with foraminal narrowing can benefit from Mild and should not be excluded from treatment.
A big thank you to Drs. @nvadvancedpain, @khemlanimd, @drpryz, and Shawn Puri for their exploration of treatment outcomes for Mild patients with and without foraminal narrowing as an adjunctive spinal comorbidity.
To learn more on why Mild should be considered a first-line therapy for LSS patients, read the full blog at the #linkinbio.
Recognizing #BackCareAwarenessWeek - Over two million lumbar spinal stenosis (#LSS) patients nationwide are diagnosed and treated annually.* Symptoms of LSS include pain, numbness, heaviness or tingling in the lower back, legs, or buttocks when standing or walking. While epidural steroid injections (ESIs) may provide short-term relief for LSS, there is a more durable, minimally invasive option available.
With a safety profile equivalent to ESIs but with lasting results, data has shown the Mild Procedure has helped 88% of patients avoid back surgery for at least 5 years.*
*View data at the #linkinbio and #MOVE2mild to help your patients achieve lasting relief.
#TreaterSpotlight We had the opportunity to speak with @droliviakelley at @wipm_society.
After her initial training, Dr. Kelley collaborated with Mild experts @drweisbein and Dr. @anjumbux. With their insights and support, Dr. Kelley has quickly adopted the Mild Procedure into her treatment algorithm for lumbar spinal stenosis (#LSS), offering patients a minimally invasive treatment that addresses a major root cause of their condition. If she performs an initial epidural steroid injection, it’s often for procedural planning, and then she’ll #MOVE2mild to help patients achieve lasting relief.*
It was great to catch up with Dr. Kelley and we look forward to watching her practice flourish with Mild!
If you’re interested in incorporating Mild into your practice, click the #linkinbio to *view data and to inquire about upcoming trainings.
#PainAwarenessMonth gives us a great opportunity to recognize Advanced Practice Providers (APPs), a vital part of the Interventional Pain Management team. APPs work alongside physicians to evaluate, educate, and assess patients.
For patients suffering from the debilitating pain and functional limitations of lumbar spinal stenosis (#LSS), APPs are often the first clinicians to recognize patients’ LSS symptoms and talk them through their care plans. We’re grateful for all the APPs who’ve helped patients #MOVE2mild.
When conservative treatments such as physical therapy, medications, and injections for lumbar spinal stenosis (#LSS) are no longer effective, patients may feel that traditional surgery is their only option for finding relief. Whether patients are not a surgical candidate, unable to tolerate surgery, or even unwilling, the Mild Procedure is a minimally invasive, outpatient treatment option that may help increase mobility and decrease pain.*
Typically completed in less than an hour, Mild can be performed through a single, tiny incision smaller than the size of a baby aspirin (5.1 mm) using only local anesthetic and light sedation, leaving no implants behind.
Make sure your patients know you have more to offer than conservative care.
*Learn more and view clinical data at the #linkinbio.
As the Mild Procedure for lumbar spinal stenosis (#LSS) becomes more widespread in clinical practice, physicians are evolving from the Standard Approach to the Streamlined Technique, a single-incision approach that increases procedural efficiency.
A recent study presented by Dr. @jassalmd and Christine Christensen, NP at #ASPN2021 demonstrates the Streamlined Technique is comparable in safety to the Standard Approach, with no increased risk of serious postoperative complications to the patient.*
*View study data at the #linkinbio.
Look for the ligament, it's a common problem, even in patients with comorbidities. Remove the problem with Mild and leave nothing behind.
Are epidural steroid injections (ESIs) falling short for your patients? Make the #MOVE2mild! Published data supports the use of the Mild Procedure after the first ESI fails.* Give your patients a safe, durable option for their lumbar spinal stenosis (#LSS) pain by incorporating Mild early in your treatment algorithm.*
*View clinical data at the #linkinbio
Look for the ligament, it’s a common problem, even in patients with comorbidities. Remove the problem with Mild and leave nothing behind.
Mild made a major impact during @pacificspineandpainsociety and @painweek in Las Vegas and we couldn’t have done it without the leadership of many outstanding doctors. We would like to extend our gratitude to Drs. @drpryz and @jassalmd for leading the Mild Procedure Symposium geared toward Primary Care Physicians (PCPs) and to Drs. @paincsd, @dr.khemlani, and @stangolovac for their leadership in the PSPS Cadaveric Lab stations.
Thank you as well to Dr. @dsayed123 for your @painweek MIST lecture, Dr. @evolve_restorative_center for your PSPS Mild lecture, and to Dr. @nvadvancedpain for your @painweek PCP Panel. Congratulations, as well, to Dr. @steven_falowski on your winning abstract.
Case history: 71 year-old male with a history of epidural steroid injections (ESIs) and lumbar neurotomy with limited relief; presenting with back and leg pain at an 8 to 10 (out of 10) that worsens with standing and walking; inability to walk more than 5-10 minutes, and relief with sitting and flexion. Imaging indicated hypertrophic ligamentum flavum ≥ 2.5 mm.
Answer: Yes! The featured patient was an excellent Mild candidate who saw significant improvement within one month post-procedure. After the Mild Procedure, the patient was able to walk and stand for 25 minutes with no pain.
At the @aspn_painneuro 2021 meeting in Miami, several abstracts highlighted recent data that supports use of the Mild Procedure as a first line therapy. Additionally, a panel of prominent Interventional Pain Physicians convened to discuss their experiences and clinical pearls for implementing the Mild Procedure in their practices. The consensus? The abstract authors and panelists repeatedly confirmed the rationale, supporting evidence and benefits of making the #MOVE2mild as a first line therapy for #LumbarSpinalStenosis (LSS).
➡️ Swipe to see why leading practices are moving to Mild and read the full blog at the #linkinbio
Thank you abstract authors and panelists: Drs. Mark Coleman, @organicstrings, @timdeer30a, @steven_falowski, @drjessicajameson, @jassalmd, Michael Leong, Nagy Mekhail, Jason Pope, @drpryz, @painkiller_photos, @dsayed123, and Lindsay Shroyer, and APP Christine Christensen.
Team Vertos has fantastic career opportunities for a variety of positions. Join a motivated team striving to help #LumbarSpinalStenosis (LSS) patients find the relief they need in a minimally invasive way.
We currently have openings for: District Sales Manager, District Sales Specialist, Principal R&D Engineer, Reimbursement Specialist, and Tableau/Salesforce Developer.
Learn more about joining Team Vertos at the #linkinbio!
Benyamin RM, Staats PS, MiDAS ENCORE Investigators. mild® is an effective treatment for lumbar spinal stenosis with neurogenic claudication: MiDAS ENCORE Randomized Controlled Trial. Pain Physician. 2016;19(4):229-242.
Mekhail N, Costandi S, Abraham B, Samuel SW. Functional and patient-reported outcomes in symptomatic lumbar spinal stenosis following percutaneous decompression. Pain Pract. 2012;12(6):417-425. doi:10.1111/j.1533-2500.2012.00565.x.
2012 data from Health Market Sciences report for Vertos Medical 2013.
Data on file with Vertos Medical.
Staats PS, Chafin TB, Golvac S, et al. Long-term safety and efficacy of minimally invasive lumbar decompression procedure for the treatment of lumbar spinal stenosis with neurogenic claudication: 2-year results of MiDAS ENCORE. Reg Anesth Pain Med. 2018;43:789-794. doi:10.1097/AAP.0000000000000868.
Based on mild® Procedure data collected in all clinical studies. Major complications are defined as dural tear and blood loss requiring transfusion.
MiDAS ENCORE responder data. On file with Vertos Medical.
Jain S, Deer TR, Sayed D, et al. Minimally invasive lumbar decompression: a review of indications, techniques, efficacy and safety. Pain Manag. 2020;10(5). https://doi.org/10.2217/pmt-2020-0037. Accessed June 1, 2020.
Deer TR, Grider JS, Pope JE, et al. The MIST Guidelines: the Lumbar Spinal Stenosis Consensus Group guidelines for minimally invasive spine treatment. Pain Pract. 2019;19(3)250-274. doi:10.1111/papr.12744.
Hansson T, Suzuki N, Hebelka H, Gaulitz A. The narrowing of the lumbar spinal canal during loaded MRI: the effects of the disc and ligamentum flavum. Eur Spine J. 2009;18(5):679-686. doi:10.1007/s00586-009-0919-7.
Treatment options shown are commonly offered once conservative therapies (e.g., physical therapy, pain medications, chiropractic) are not providing adequate relief. This is not intended to be a complete list of all treatments available. Doctors typically recommend treatments based on their safety profile, typically prioritizing low risk/less aggressive procedures before higher risk/more aggressive procedures, but will determine which treatments are appropriate for their patients.
Although the complication rate for the mild® Procedure is low, as with most surgical procedures, serious adverse events, some of which can be fatal, can occur, including heart attack, cardiac arrest (heart stops beating), stroke, and embolism (blood or fat that migrates to the lungs or heart). Other risks include infection and bleeding, spinal cord and nerve injury that can, in rare instances, cause paralysis. This procedure is not for everyone. Physicians should discuss potential risks with patients. For complete information regarding indications for use, warnings, precautions, and methods of use, please reference the devices’Instructions for Use.
Patient stories on this website reflect the results experienced by individuals who have undergone the mild® Procedure. Patients are not compensated for their testimonial. The mild® Procedure is intended to treat lumbar spinal stenosis (LSS) caused by ligamentum flavum hypertrophy. Although patients may experience relief from the procedure, individual results may vary. Individuals may have symptoms persist or evolve or other conditions that require ongoing medication or additional treatments. Please consult with your doctor to determine if this procedure is right for you.
Reimbursement, especially coding, is dynamic and changes every year. Laws and regulations involving reimbursement are also complex and change frequently. Providers are responsible for determining medical necessity and reporting the codes that accurately describe the work that is done and the products and procedures that are furnished to patients. For this reason, Vertos Medical strongly recommends that you consult with your payers, your specialty society, or the AMA CPT regarding coding, coverage and payment.
Vertos Medical cannot guarantee coding, coverage, or payment for products or procedures. View our Billing Guide.
Vertos is an equal employment opportunity workplace committed to pursuing and hiring a diverse workforce. We strive to grow our team with highly skilled people who share our culture and values. All qualified applicants will receive consideration for employment without regard to sex, age, color, race, religion, marital status, national origin, ancestry, sexual orientation, gender identity, physical & mental disability, medical condition, genetic information, veteran status, or any other basis protected by federal, state or local law.
Hall S, Bartleson JD, Onofrio BM, Baker HL Jr, Okazaki H, O’Duffy JD. Lumbar spinal stenosis. Clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med. 1985;103(2):271-275. doi:10.7326/0003-4819-103-2-271.
Kalichman L, Cole R, Kim DH, et al. Spinal stenosis prevalence & association with symptoms: The Framingham Study. Spine J. 2009;9(7):545-550. doi:10.1016/j.spinee.2009.03.005.
Fukusaki M, Kobayashi I, Hara T, Sumikawa K. Symptoms of spinal stenosis do not improve after epidural steroid injection. Clin J Pain. 1998;14(2):148-151. doi:10.1097/00002508-199806000-00010.
Mekhail N, Costandi S, Nageeb G, Ekladios C, Saied O. The durability of minimally invasive lumbar decompression procedure in patients with symptomatic lumbar spinal stenosis: Long-term follow-up [published online ahead of print, 2021 May 4]. Pain Pract. 2021;10.1111/papr.13020. doi:10.1111/papr.13020
Friedly JL, Comstock BA, Turner JA, et al. Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Arch Phys Med Rehabil. 2017;98(8):1499-1507.e2. doi:10.1016/j.apmr.2017.02.029
Pope J, Deer TR, Falowski SM. A retrospective, single-center, quantitative analysis of adverse events in patients undergoing spinal stenosis with neurogenic claudication using a novel percutaneous direct lumbar decompression strategy. J Pain Res. 2021;14:1909-1913. doi: 10.2147/JPR.S304997
Pryzbylkowski P, Bux A, Chandwani K, et al. Minimally invasive direct decompression for lumbar spinal stenosis: impact of multiple prior epidural steroid injections [published online ahead of print, 2021 Aug 4]. Pain Manag. 2021;10.2217/pmt-2021-0056. doi:10.2217/pmt-2021-0056
Abstract presented at: American Society of Pain and Neuroscience Annual Conference; July 22-25, 2021; Miami Beach, FL.